August 2010

Japanese Markets for Trauma Devices 2010

Introduction:

Through 2014, revenues generated by the Japanese trauma device market will be stagnant. Growth in procedure volumes will be attributed to the aging population in Japan, which will primarily fuel uptake of internal fixation devices (plates and screws, intramedullary [IM] nails, cannulated screws, and compression hip screws). In addition, surgeons are increasingly adopting innovative devices—such as anatomic, locking, small and mini standard plates, as well as cephalomedullary nails—that are backed by clinical data suggesting that they offer improved outcomes. These devices offer surgeons more options for open reduction internal fixation of fractures that may otherwise have been treated with a cast or splint. Surgeons are also adopting circular and hybrid external fixation devices for elective procedures, such as limb deformity corrections. Nevertheless, market growth for internal fixation devices will be offset by biennial reimbursement cuts instituted by the Ministry of Health, Labour and Welfare (MHLW) in order to curb rising health care costs. This will create downward pressure on average selling prices (ASPs), thereby impeding revenue gains. Although external fixation devices are not reimbursed in Japan, sales of the devices will also be limited by declining rates of motor vehicle and industrial accidents as a result of improved safety measures established by the Japanese government. Consequently, overall growth of the Japanese market for trauma devices will be negligible over the forecast period.

Questions Answered in This Report:

  *   Japanese surgeons are increasingly adopting premium-priced locking and anatomic plates over noncephalomedullary nails for open reduction internal fixation of long-bone fractures. How will the market for anatomic plates grow relative to the IM nail market as more indication-specific noncephalomedullary nails become available in Japan? Will this trend be sustained over the forecast period through the introduction of novel plating systems in Japan?

  *   In Japan, biennial reimbursement cuts instituted by the MHLW in order to realize health care cost savings will negatively impact device ASPs. As surgeons increasingly adopt plates and screws over noncephalomedullary nails for fracture management, how will reimbursement for noncephalomedullary nails change with respect to premium-priced anatomic and locking plates? Will the premium charged for anatomic and locking plates be sustained over the forecast period?

  *   Japanese surgeons are increasingly adopting cephalomedullary nails over compression and cannulated hip screws due to data suggesting improved clinical outcomes for IM nails. How will the market for cephalomedullary nails grow relative to the markets for compression hip screws and cannulated screws? How will reimbursement rates and ASPs differ for these devices?

Scope:

Regions covered:

Segmentation: Our analysis uses the following segmentation of the market:

  • Internal fixation devices
    • Intramedullary nails
      • By material (stainless steel and titanium)
      • By indication (cephalomedullary, femoral, tibial, humeral, and other [radius, ulna, fibula, and ankle])
    • Plate and screws
      • By material (stainless steel and titanium)
      • By mechanism (locking and nonlocking)
      • By type (anatomic by indication [wrist, ankle, and other (olecranon, ulna, tibia, fibula, humerus, and clavicle)] and standard by size [large, small, and mini])
    • Compression hip screws
      • By material (stainless steel and titanium)
    • Cannulated screws
      • By material (stainless steel and titanium)
  • External fixation devices
    • By type (circular, hybrid, lateral, pelvic, other [devices for the olecranon and ulna])

Market forecast features: Based on primary research with industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2008–2014).

Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.

Authors:

Arun Jaganathan



Search Reports

CONTACT US
Email Opt-in: I consent to receive e-mails from DRG regarding healthcare market information, product announcements, promotions, webinar and seminar invitations and other messages. I understand that I may withdraw my consent and unsubscribe or update my email preferences at any time. Please read our Terms of Use and Privacy Policy and contact us with any questions.

Mentioned in this report:

  • B. Braun Aesculap
  • BEST MEDICAL
  • Biomet
  • DePuy (through distributor Japan Medical Dynamic Marketing)
  • HOLLYX
  • Japan Medical Materials
  • MEIRA Corporation
  • Mizuho Medical
  • MMT Co. Ltd
  • Nihon Unitec
  • Orthofix (through distributor Kobayashi Pharmaceutical)
  • Small Bone Innovations
  • Smith & Nephew
  • Stryker
  • Synthes
  • Zimmer
Decision Resources Group brands include: